Investor relations

Investor relations

Investor Relations presentation

Download our presentation to review our latest financial information, product performance and see progress on our development pipeline of potential new medicines. Updated following our Q2 and half year results 2014.

Investor Relations presentation (PDF 7062kb)

Latest downloads

Second quarter and half year results 2014

31 July 2014

Strategic Transaction with Almirall

30 July 2014

American Society of Clinical Oncology

3 June 2014

American Thoracic Society AstraZeneca Analyst briefing

20 May 2014


Annual Report 2013

AstraZeneca Annual Report 2013

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.


Currency guidance 2014

In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.

The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.

View 2014 currency guidance


Keeping investors in touch

Download our iPad app now from the app store

AstraZeneca Investor Relations iPad app

The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.

Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.

Download and install from the iTunes store


Share price

London
45.41 GBP
New York
74.75 USD
Stockholm
526.00 SEK

At 2-9-2014 17:33 GMT

Detailed share price


Stock symbol - AZN

On LSE, NYE and OMX